Lisinopril

Product NDC
63629-6526
Requested package NDC
63629-6526-3
11-digit product format
636296526
Labeler code
63629
Product ID
63629-6526_8b28e0f3-813c-48e8-92b7-93e74ac8ea6d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lisinopril
Dosage form
TABLET
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA077321
Marketing category
ANDA
Marketing start
2006-01-13
Marketing end
0000-00-00
Substance
LISINOPRIL
Active strength
10 mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage63629-652663629-6526-3DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 13 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Code, Status table
Captured / source dateCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10DDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31DDiscontinued by firm302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20DDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10DDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08DDiscontinued by firmad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03DDiscontinued by firm367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09DDiscontinued by firm557ba5c1ecfa…9c80585c8c6e…
2020-06-10 20:45 UTC · source 2020-06-10IInactivated by FDA9bebd1f3094a…5416666fcb17…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 6 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A077321-001LISINOPRILLISINOPRIL2.5MGTABLET / ORALAB2005-09-09
A077321-002LISINOPRILLISINOPRIL5MGTABLET / ORALAB2005-09-09
A077321-003LISINOPRILLISINOPRIL10MGTABLET / ORALAB2005-09-09
A077321-004LISINOPRILLISINOPRIL20MGTABLET / ORALAB2005-09-09
A077321-005LISINOPRILLISINOPRIL30MGTABLET / ORALAB2005-09-09
A077321-006LISINOPRILLISINOPRIL40MGTABLET / ORALAB2005-09-09

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 6 matching rows.

Application-product, TE code table
Application-productTE code
A077321-001AB
A077321-002AB
A077321-003AB
A077321-004AB
A077321-005AB
A077321-006AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 7 · 258 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A077321-001LISINOPRIL2.5MGTABLET / ORALAB2005-09-0984e616aacf4f…
2026-09-14 22:38:342026-08A077321-002LISINOPRIL5MGTABLET / ORALAB2005-09-0984e616aacf4f…
2026-09-14 22:38:342026-08A077321-003LISINOPRIL10MGTABLET / ORALAB2005-09-0984e616aacf4f…
2026-09-14 22:38:342026-08A077321-004LISINOPRIL20MGTABLET / ORALAB2005-09-0984e616aacf4f…
2026-09-14 22:38:342026-08A077321-005LISINOPRIL30MGTABLET / ORALAB2005-09-0984e616aacf4f…
2026-09-14 22:38:342026-08A077321-006LISINOPRIL40MGTABLET / ORALAB2005-09-0984e616aacf4f…
2026-08-18 06:07:402026-07A077321-001LISINOPRIL2.5MGTABLET / ORALAB2005-09-09caaa826d4ba7…
2026-08-18 06:07:402026-07A077321-002LISINOPRIL5MGTABLET / ORALAB2005-09-09caaa826d4ba7…
2026-08-18 06:07:402026-07A077321-003LISINOPRIL10MGTABLET / ORALAB2005-09-09caaa826d4ba7…
2026-08-18 06:07:402026-07A077321-004LISINOPRIL20MGTABLET / ORALAB2005-09-09caaa826d4ba7…
2026-08-18 06:07:402026-07A077321-005LISINOPRIL30MGTABLET / ORALAB2005-09-09caaa826d4ba7…
2026-08-18 06:07:402026-07A077321-006LISINOPRIL40MGTABLET / ORALAB2005-09-09caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A077321-001LISINOPRIL2.5MGTABLET / ORALAB2005-09-09011fe1cb6892…
2026-02-19 14:30 UTC2026-02A077321-002LISINOPRIL5MGTABLET / ORALAB2005-09-09011fe1cb6892…
2026-02-19 14:30 UTC2026-02A077321-003LISINOPRIL10MGTABLET / ORALAB2005-09-09011fe1cb6892…
2026-02-19 14:30 UTC2026-02A077321-004LISINOPRIL20MGTABLET / ORALAB2005-09-09011fe1cb6892…
2026-02-19 14:30 UTC2026-02A077321-005LISINOPRIL30MGTABLET / ORALAB2005-09-09011fe1cb6892…
2026-02-19 14:30 UTC2026-02A077321-006LISINOPRIL40MGTABLET / ORALAB2005-09-09011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077321-001LISINOPRIL2.5MGTABLET / ORALAB2005-09-0931067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077321-002LISINOPRIL5MGTABLET / ORALAB2005-09-0931067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077321-003LISINOPRIL10MGTABLET / ORALAB2005-09-0931067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077321-004LISINOPRIL20MGTABLET / ORALAB2005-09-0931067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077321-005LISINOPRIL30MGTABLET / ORALAB2005-09-0931067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077321-006LISINOPRIL40MGTABLET / ORALAB2005-09-0931067a03dcf5…
2025-08-23 18:47 UTC2025-08A077321-001LISINOPRIL2.5MGTABLET / ORALAB2005-09-096a471c1ec25d…
2025-08-23 18:47 UTC2025-08A077321-002LISINOPRIL5MGTABLET / ORALAB2005-09-096a471c1ec25d…
2025-08-23 18:47 UTC2025-08A077321-003LISINOPRIL10MGTABLET / ORALAB2005-09-096a471c1ec25d…
2025-08-23 18:47 UTC2025-08A077321-004LISINOPRIL20MGTABLET / ORALAB2005-09-096a471c1ec25d…
2025-08-23 18:47 UTC2025-08A077321-005LISINOPRIL30MGTABLET / ORALAB2005-09-096a471c1ec25d…
2025-08-23 18:47 UTC2025-08A077321-006LISINOPRIL40MGTABLET / ORALAB2005-09-096a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077321-001LISINOPRIL2.5MGTABLET / ORALAB2005-09-09fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077321-002LISINOPRIL5MGTABLET / ORALAB2005-09-09fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077321-003LISINOPRIL10MGTABLET / ORALAB2005-09-09fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077321-004LISINOPRIL20MGTABLET / ORALAB2005-09-09fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077321-005LISINOPRIL30MGTABLET / ORALAB2005-09-09fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077321-006LISINOPRIL40MGTABLET / ORALAB2005-09-09fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A077321-001LISINOPRIL2.5MGTABLET / ORALAB2005-09-09b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A077321-002LISINOPRIL5MGTABLET / ORALAB2005-09-09b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A077321-003LISINOPRIL10MGTABLET / ORALAB2005-09-09b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A077321-004LISINOPRIL20MGTABLET / ORALAB2005-09-09b8a1b40f171c…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 7 · 258 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A077321-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A077321-002AB184e616aacf4f…
2026-09-14 22:38:342026-08A077321-003AB184e616aacf4f…
2026-09-14 22:38:342026-08A077321-004AB184e616aacf4f…
2026-09-14 22:38:342026-08A077321-005AB184e616aacf4f…
2026-09-14 22:38:342026-08A077321-006AB184e616aacf4f…
2026-08-18 06:07:402026-07A077321-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A077321-002AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A077321-003AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A077321-004AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A077321-005AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A077321-006AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A077321-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A077321-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A077321-003AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A077321-004AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A077321-005AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A077321-006AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077321-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077321-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077321-003AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077321-004AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077321-005AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077321-006AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A077321-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A077321-002AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A077321-003AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A077321-004AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A077321-005AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A077321-006AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077321-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077321-002AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077321-003AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077321-004AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077321-005AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077321-006AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A077321-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A077321-002AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A077321-003AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A077321-004AB1b8a1b40f171c…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
63629-6526-12020-10-16These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988
63629-6526-22020-10-16These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988
63629-6526-32020-10-16These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988
63629-6526-12020-01-31These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988
63629-6526-22020-01-31These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988
63629-6526-32020-01-31These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS. LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 3 · 57 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LisinoprilLISINOPRILREMEDYREPACK INC.aa5d68e7-c2b9-41eb-ade4-2cd57edc15332026-09-10Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077321
application number: ANDA077321
LisinoprilLISINOPRILREMEDYREPACK INC.463308ef-16cb-41d8-8d29-6aae2c5a7b0f2026-08-04Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077321
application number: ANDA077321
LisinoprilLISINOPRILREMEDYREPACK INC.34bb4602-ccff-4939-91b9-26a63bfd40f72026-08-04Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077321
application number: ANDA077321
LisinoprilLISINOPRILREMEDYREPACK INC.a33d860a-1e17-45b7-aede-51ab3223bebd2026-07-15Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077321
application number: ANDA077321
LisinoprilLISINOPRILA-S Medication Solutions88b5a2c0-6ad2-48e7-9ffe-715d9159f3892026-07-06Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077321
application number: ANDA077321
LisinoprilLISINOPRILA-S Medication Solutions34953f77-bae1-41fe-af11-3ea0b3ceaa112026-07-06Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077321
application number: ANDA077321
LisinoprilLISINOPRILREMEDYREPACK INC.3451292b-7867-4dc2-afaa-da66b40160172026-07-03Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077321
application number: ANDA077321
LisinoprilLISINOPRILREMEDYREPACK INC.d32923fe-a323-43c6-af46-bcba7274b0bf2026-07-03Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077321
application number: ANDA077321
LisinoprilLISINOPRILUnit Dose Solutions, Inc.551665a0-9a92-55df-e063-6394a90a1e2e2026-06-25Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077321
application number: ANDA077321
LisinoprilLISINOPRILUnit Dose Solutions, Inc.55189717-f5db-9c63-e063-6294a90a6bc92026-06-25Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077321
application number: ANDA077321
LisinoprilLISINOPRILUnit Dose Solutions, Inc.55191baa-f812-2e71-e063-6294a90a8edf2026-06-25Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077321
application number: ANDA077321
LisinoprilLISINOPRILPD-Rx Pharmaceuticals, Inc.c621c33b-cb67-4ea6-b2bd-96c20a244ea42026-06-12Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077321
application number: ANDA077321
LisinoprilLISINOPRILCoupler LLC538429b8-4f10-e825-e063-6294a90a59052026-06-05Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077321
application number: ANDA077321
LisinoprilLISINOPRILCardinal Health 107, LLC1d0caa63-9ea2-4a97-a23b-900a7c514bc62026-05-20Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077321
application number: ANDA077321
LisinoprilLISINOPRILCoupler LLC518a63e3-8ca1-bbd1-e063-6294a90aa5242026-05-11Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077321
application number: ANDA077321
LisinoprilLISINOPRILCoupler LLC509a46cf-7a89-b6c0-e063-6394a90a75092026-04-29Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077321
application number: ANDA077321
LisinoprilLISINOPRILBryant Ranch Prepack08b0555e-41d2-44c3-b27b-ad5d701378dc2026-04-03Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077321
application number: ANDA077321
LisinoprilLISINOPRILBryant Ranch Prepack59fd2167-4da4-9143-83bd-3b6aa50515112026-03-24Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077321
application number: ANDA077321
LisinoprilLISINOPRILREMEDYREPACK INC.a35079fa-b693-45e8-9715-488e33e7c1a92026-02-09Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077321
application number: ANDA077321
LisinoprilLISINOPRILREMEDYREPACK INC.f22bfb4d-dda6-4c7f-a485-cfb7710ef3de2026-01-09Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 077321
application number: ANDA077321

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
63629-6526-36362965260390 TABLET in 1 BOTTLE (63629-6526-3) 90 tablet2015-07-270000-00-00NoNoCurrent